Brigitte M. Ronnett

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Vaccination, Vaccinology, Vaccine Development +9

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

Teresa M. Darragh, Terence J. Colgan, J. Thomas Cox et al. · Archives of Pathology & Laboratory Medicine · 2012 · 977 citations · Full text

Gynecology, Pathology, Cytopathology +21

The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin

Jeffrey D. Seidman, Iren Horkayne‐Szakaly, Moutaz Haiba et al. · International Journal of Gynecological Pathology · 2003 · 556 citations

Tumoral Pathology, Gynecological Surgery, Stage Distribution +14

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano et al. · Vaccine · 2006 · 465 citations

Vaccination, Vaccine Development, Human Papillomavirus Vaccines +9

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Warner K. Huh, Elmar A. Joura, Anna R. Giuliano et al. · The Lancet · 2017 · 448 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +11